For weight management, NICE (TA664) recommends these medications within specialist weight management services for people with a BMI of at least 35 kg/m (or 32.5 kg/m in people from minority ethnic backgrounds) with non-diabetic hyperglycaemia and a high risk of cardiovascular disease, or a BMI of at least 30 kg/m with type 2 diabetes
Se supplementation in critically ill patients has been reported to lower mortality rates, organ failure, and infections compared to the control group [18, 19]
Today, theyre widely prescribed for weight loss, cardiovascular risk reduction, and emerging indications such as sleep apnea, PCOS, and non-alcoholic fatty liver disease (NAFLD)
(2022) 81:e42
These more indirect mechanisms associated with redox perturbations in ALS are described in detail below
Divide doses for improved tolerance